A recent Paediatrics digest,
as sent to subscribers

Study Type: Nationwide population-based cohort study with sibling-comparison analysis (Sweden, 1987–2021 birth cohort)

Key Question: Are congenital TORCH infections independently associated with neurodevelopmental and psychiatric outcomes, after accounting for familial confounding?

Key Findings:

• Congenital TORCH infection strongly associated with intellectual disability (HR 7.22, 95% CI 6.14–8.49) and autism (HR 3.10, 95% CI 2.55–3.76), with similar or stronger effects in sibling-controlled models (ID: HR 11.28; autism: HR 3.19).
• Risk increased with severity of intellectual disability (mild HR 3.01 to profound HR 23.51) and was greater for autism with co-occurring intellectual disability (HR 6.23 vs 1.97 without).
• No robust association with OCD; ADHD association attenuated in sibling analysis. Exposed individuals had lower adolescent school grades (−1.50 points, 95% CI −2.60 to −0.40).

Clinical Relevance: Reinforces the case for robust UK antenatal/neonatal screening, vaccination (rubella), and infection prevention pathways (e.g., CMV awareness, syphilis screening), given long-term neurodevelopmental burden even after accounting for shared family factors.

Limitations: Exposure relied on clinically diagnosed (likely symptomatic/severe) TORCH infections identified via registers, so findings may not generalise to milder or subclinical congenital infections.

Study Type: Cross-sectional survey analysis with trend comparison (National Health Interview Survey, USA)

Key Question: Has the parent-reported prevalence of developmental disabilities in US children aged 3–17 changed between 2019 and 2024?

Key Findings:

• Overall parent-reported developmental disability prevalence rose from 16.7% to 20.5% (P<.001), even after adjustment for demographic/socioeconomic factors.
• Significant increases seen in ADHD (9.5%→12.0%), autism spectrum disorder (3.1%→4.5%), learning disability (7.6%→8.8%), and other developmental delay (5.5%→6.4%; all P<.05).
• Intellectual disability prevalence did not significantly change.

Clinical Relevance: Although US-based, these findings mirror ongoing UK trends in rising neurodevelopmental diagnosis rates, relevant to NHS community paediatrics and SEND service planning and capacity pressures.

Limitations: Diagnoses relied solely on parental report of prior clinician diagnosis, without independent clinical verification, limiting causal interpretation of true prevalence change versus improved detection/awareness.

Study Type: Case series (n=3 siblings) with accompanying diagnostic algorithm proposal

Key Question: How should clinicians recognise and diagnose hereditary TTP in neonates presenting with unexplained hemolytic anaemia and jaundice?

Key Findings:

• Three siblings with ADAMTS13 loss-of-function variants all required neonatal exchange transfusion; hTTP diagnosis was delayed until age 13–18 years, with one sibling suffering a neonatal stroke and another undergoing an unnecessary leukaemia workup in childhood.
• Only 5% of hTTP patients are correctly diagnosed at birth according to cited data, despite nearly half being symptomatic neonatally.
• Two siblings now receive recombinant ADAMTS13 replacement in adulthood, newly FDA-approved.

Clinical Relevance: UK neonatologists should maintain a high index of suspicion for hTTP in neonates with nonimmune hemolytic anaemia and recalcitrant jaundice, as early ADAMTS13 testing could prevent exchange transfusions, diagnostic delay, and irreversible neurologic/renal damage, now that targeted enzyme replacement therapy exists.

Limitations: Findings are based on a single-family case series, limiting generalisability of the proposed diagnostic algorithm.

Study Type: Retrospective cohort study (national registry analysis)

Key Question: Does head CT use for paediatric mild traumatic brain injury vary by hospital type (adult, paediatric, mixed) in the US National Trauma Data Bank, 2017–2023?

Key Findings:

• Among 12,030 children with isolated mTBI, overall CT use remained high (43.5–51.5%) with little change over 7 years.
• Adult hospitals had markedly higher CT rates (59.5%) than mixed (44.0%) and paediatric hospitals (38.8%).
• Higher imaging rates were associated with lower GCS, impaired consciousness, and treatment at nonteaching or smaller hospitals.

Clinical Relevance: Highlights persistent overuse of CT in mild paediatric head injury despite established guidance (e.g., PECARN, NICE), reinforcing the need for consistent application of validated decision rules in UK EDs, especially non-specialist/adult-facing units seeing children.

Limitations: US registry data with no direct data on clinical decision-rule application, limiting generalisability to UK practice and causal inference about guideline non-adherence.

Study Type: RCT (3-arm, effectiveness-implementation hybrid type 1)

Key Question: Do text message reminders, alone or combined with referral to community resources, enhance the impact of primary care literacy promotion (Reach Out and Read) for Latino caregiver-infant dyads?

Key Findings:

• At 18 months, LP+texts (vs LP-only) improved child language scores (ES=0.391, adj. P=.001); LP+texts+CNJ did not.
• LP+texts+CNJ improved social-emotional development at 9 and 18 months (ES=0.267–0.300, adj. P≤.04) and verbal responsiveness at 9 months (ES=0.400, adj. P<.001).
• LP+texts alone improved reading behaviours at 9 months (ES=0.415, adj. P=.002).

Clinical Relevance: Scalable, low-cost text-based adjuncts to literacy promotion could strengthen relational and developmental outcomes for linguistically diverse, low-income families seen in UK primary/community child health settings, informing digital health equity strategies.

Limitations: Differential effects across arms and outcome domains suggest mechanisms are not fully understood, limiting clarity on optimal implementation strategy.

Study Type: Systematic review and meta-analysis of RCTs

Key Question: Do behavioural adherence-promoting interventions improve glycaemic control (HbA1C) in youth with type 1 diabetes, and which intervention formats are most effective?

Key Findings:

• Across 46 RCTs, behavioural interventions had a small overall effect on HbA1C (Hedges' g = 0.12); pilot RCTs showed larger effects (g = 0.36) than full-scale RCTs (g = 0.07), suggesting inflated efficacy in early-phase trials.
• Multicomponent interventions (targeting both direct and indirect self-management processes) outperformed single-focus interventions (g = 0.19 vs 0.08–0.15).
• Family-focused interventions were most effective (g = 0.29) compared with youth-only (g = 0.05) or parent-only (g = 0.04) approaches.

Clinical Relevance: Despite widespread adoption of diabetes technology, structured multicomponent, family-centred behavioural support remains relevant and should be considered alongside technology in NHS paediatric diabetes services to support HbA1C targets.

Limitations: Analysis is restricted to published RCTs, with effect sizes generally small and full-scale trials showing markedly weaker effects than pilot studies, raising concerns about publication bias and real-world effectiveness.

Study Type: Retrospective, single-center cohort study

Key Question: In infants born at 21–24 weeks' gestation, are early clinical-hemodynamic PDA phenotypes and echocardiographic PDA characteristics associated with survival without major morbidity?

Key Findings:

• Favorable outcome occurred in 46.6% (88/189); outcomes differed significantly across 4 PDA phenotypes (p=0.003), with ductal-supportive physiology associated with worse outcomes (70.8% unfavorable vs 49.6%, p=0.012).
• Larger indexed PDA diameter was associated with lower odds of favorable outcome (OR 0.76, 95% CI 0.59–0.98, p=0.034), but a non-linear pattern (worst outcomes at extremes of diameter) suggests complexity beyond simple linearity.
• Both key associations were attenuated and lost statistical significance after excluding early deaths, indicating fragility of findings.

Clinical Relevance: As UK neonatal units increasingly resuscitate infants at 22–23 weeks' gestation, early TNE-based PDA phenotyping may offer exploratory prognostic markers to inform counselling and management discussions, though not yet a validated clinical tool.

Limitations: Single-center, retrospective design with center-specific phenotype definitions and outcome attenuation after excluding early deaths precludes causal inference or generalisability.

Study Type: Retrospective single-centre before-and-after implementation study

Key Question: Does prenatal risk stratification combined with non-invasive postnatal monitoring (deferring empiric PGE) safely reduce unnecessary medicalisation in neonates with suspected prenatal coarctation of the aorta (CoA)?

Key Findings:

• Post-protocol, low-risk fetuses had only 7% probability of surgical CoA (95% CI 1–31%) vs 68% (95% CI 46–85%) in high-risk group; specificity of high-risk classification was 77%.
• PGE exposure significantly reduced post-protocol (p=0.037), with elimination of PGE use in false-positive cases.
• False-positive cases showed significant reductions in tertiary transfer (p=0.006), feeding delay (p=0.001), and central line placement (p=0.002); one late-recognised CoA developed ventricular dysfunction before PGE initiation.

Clinical Relevance: Supports a shift toward selective, risk-stratified postnatal monitoring rather than routine empiric PGE/central access for prenatally suspected CoA, potentially reducing NHS resource use and iatrogenic harm, though careful safety-netting for missed cases remains essential.

Limitations: Small post-protocol cohort (n=42) from a single centre limits generalisability and statistical power, particularly regarding rare adverse outcomes like missed CoA.